Profile data is unavailable for this security.
About the company
Bon Natural Life Ltd is a China-based company principally engaged in the manufacturing and sales of personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers, natural health supplements, such as powder drinks and bioactive food ingredient products mostly used as food additives and nutritional supplements. The Company's product categories include fragrance compounds, health supplements (natural, functional active ingredients for powder drinks) and bioactive food ingredients. Fragrance compounds product category includes clary sage extract products. Bioactive food ingredients include stachyose, milk thistle extracts, apple extracts, phloretin and pomegranate extract products. The Company’s products are applied in the functional food, personal care, cosmetic and pharmaceutical industries.
- Revenue in USD (TTM)29.52m
- Net income in USD4.60m
- Incorporated2019
- Employees96.00
- LocationBon Natural Life LtdC601, Gazelle Valley, No.69Jinye Rd., Xi'an-Tech ZoneXI'AN 710076ChinaCHN
- Phone+86 2 988346301
- Websitehttps://www.bnlus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aditxt Inc | 645.19k | -32.70m | 3.35m | 47.00 | -- | 0.1651 | -- | 5.19 | -153.12 | -153.12 | 2.14 | 12.17 | 0.0233 | 0.8927 | 1.38 | 13,727.45 | -117.12 | -192.78 | -251.19 | -321.59 | -17.30 | -- | -5,020.30 | -7,208.65 | 0.2382 | -4.09 | 0.5020 | -- | -30.90 | -- | -18.11 | -- | -- | -- |
| Cyclacel Pharmaceuticals Inc | 420.00k | -22.76m | 3.35m | 12.00 | -- | 3.99 | -- | 7.98 | -26.72 | -26.72 | 0.4924 | 0.5732 | 0.0228 | -- | 0.1106 | -- | -122.40 | -57.58 | -212.95 | -69.81 | -- | -- | -5,370.24 | -18,789.29 | -- | -170.83 | 0.00 | -- | -- | 22.87 | -6.34 | -- | -31.23 | -- |
| Manuka Inc | 671.00k | -1.14m | 3.36m | 4.00 | -- | -- | -- | 5.01 | -0.0128 | -0.0128 | 0.0066 | -0.0124 | 2.41 | 0.9412 | 37.28 | 167,750.00 | -410.43 | -463.75 | -- | -- | 88.08 | -- | -170.04 | -732.15 | 0.0194 | -- | -- | -- | -- | -- | -854.23 | -- | -- | -- |
| Cannapharmarx Inc | 0.00 | -7.50m | 3.38m | 6.00 | -- | -- | -- | -- | -0.0274 | -0.0274 | 0.00 | -0.0715 | 0.00 | -- | -- | 0.00 | -141.75 | -161.34 | -- | -- | -- | -- | -- | -- | -- | -3.49 | -- | -- | -- | -- | 3.41 | -- | -- | -- |
| ENDRA Life Sciences Inc | 0.00 | -10.06m | 3.39m | 21.00 | -- | 0.5639 | -- | -- | -1.93 | -1.93 | 0.00 | 0.5447 | 0.00 | -- | -- | 0.00 | -125.53 | -132.00 | -149.91 | -157.28 | -- | -- | -- | -- | -- | -- | 0.005 | -- | -- | -- | 23.67 | -- | -19.46 | -- |
| Zyversa Therapeutics Inc | 0.00 | -106.25m | 3.41m | 7.00 | -- | 0.1642 | -- | -- | -1,922.89 | -1,922.89 | 0.00 | 27.33 | 0.00 | -- | -- | 0.00 | -139.81 | -- | -160.83 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -340.15 | -- | -- | -- |
| Onconetix Inc | 58.47k | -37.41m | 3.48m | 12.00 | -- | -- | -- | 59.57 | -2.09 | -2.09 | 0.0034 | 2.63 | 0.001 | -- | 0.6301 | 4,872.50 | -65.73 | -- | -87.29 | -- | -1,927.76 | -- | -63,981.00 | -- | 0.3185 | -19.88 | 0.1292 | -- | -- | -- | -176.78 | -- | -- | -- |
| Altamira Therapeutics Ltd | 0.00 | -8.00m | 3.49m | 10.00 | -- | 0.3244 | -- | -- | -16.28 | -8.67 | 0.00 | 4.81 | 0.00 | 34.05 | 32.30 | 0.00 | -103.88 | -73.80 | -6,364.67 | -123.19 | -87.90 | -- | -- | -- | 1.38 | -4.37 | 0.0152 | -- | -- | -- | 61.02 | -- | -- | -- |
| Bon Natural Life Ltd | 29.52m | 4.60m | 3.53m | 96.00 | 0.5070 | 0.0837 | 0.6403 | 0.1195 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
| Bio Path Holdings Inc | 0.00 | -13.96m | 3.54m | 10.00 | -- | -- | -- | -- | -27.39 | -27.39 | 0.00 | -3.48 | 0.00 | -- | -- | 0.00 | -216.97 | -70.80 | -390.65 | -76.87 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -15.94 | -- | -- | -- |
| Phio Pharmaceuticals Corp | 0.00 | -9.38m | 3.61m | 8.00 | -- | 0.6448 | -- | -- | -3.71 | -3.71 | 0.00 | 1.22 | 0.00 | -- | -- | 0.00 | -113.26 | -71.92 | -145.23 | -84.15 | -- | -- | -- | -253,785.70 | -- | -- | 0.00 | -- | -- | -- | 5.70 | -- | 0.00 | -- |
| Atreca Inc | 0.00 | -97.76m | 3.65m | 90.00 | -- | 0.3388 | -- | -- | -2.49 | -2.49 | 0.00 | 0.2715 | 0.00 | -- | -- | 0.00 | -98.54 | -44.99 | -116.19 | -48.05 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 11.13 | -- | -8.46 | -- |
| Sonoma Pharmaceuticals Inc | 12.31m | -5.08m | 3.68m | 9.00 | -- | 0.4826 | -- | 0.2992 | -0.9608 | -0.9608 | 1.95 | 0.489 | 0.8625 | 2.58 | 4.76 | 1,367,778.00 | -35.56 | -37.52 | -47.14 | -51.35 | 39.17 | 40.17 | -41.23 | -37.12 | 3.11 | -- | 0.0065 | -- | 5.10 | -4.44 | -1.28 | -- | 7.54 | -- |
| Scorpius Holdings Inc | 2.23m | -46.05m | 3.73m | 77.00 | -- | 0.0744 | -- | 1.67 | -1.78 | -2.00 | 0.0859 | 1.39 | 0.0234 | -- | 0.6762 | 28,918.57 | -50.05 | -38.42 | -61.25 | -42.06 | 29.10 | -- | -2,136.28 | -703.02 | -- | -- | 0.2305 | -- | 202.12 | 33.24 | -23.85 | -- | 218.50 | -- |
Data as of May 17 2024. Currency figures normalised to Bon Natural Life Ltd's reporting currency: US Dollar USD
0.40%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Citadel Securities LLCas of 31 Mar 2024 | 3.62k | 0.26% |
| Virtu Americas LLCas of 31 Dec 2023 | 1.90k | 0.14% |
| UBS Securities LLCas of 31 Mar 2024 | 15.00 | 0.00% |
| JPMorgan Securities LLC (Investment Management)as of 31 Mar 2024 | 0.00 | 0.00% |
| XTX Markets LLCas of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
